Skip to content

Drug Regulatory Authority of Pakistan

Ministry of National Health Services, Regulations & Coordination

اردو | English

facebook
twitter
envelope

Menu

About Us
Therapeutic Goods
Safety Info
News & Updates
Publications
E-Services
- MIS Systems
- Online Data Verification
Support
- Facilitation Desk
- Complaints

Home > News & Updates > Regulatory Updates > Alternative Medicines > Notification F.No.8-3/2019-H&OTC

Notification F.No.8-3/2019-H&OTC

Murtaza Awan Alternative Medicines September 2, 2021December 29, 2021HOTC

Guidelines for manufacturing of Alternative Medicines, Health Products and Probiotic by the DML holders.

notification Download

Share this:

Twitter
Facebook

← Conduct Of Clinical Trials Guidelines (v2.0) Stake holders are invited for comments to be submitted within 15 days to email: drap.pharmacy@gmail.com
Notification F.No.4-2/2017-DD (H&OTC) →

Drugs
Medical Devices
Alternative Medicines
Controlled Substances
Licensing and Inspections
Clinical Trials
Pharmacovigilance
Advertisements
General

Quick Navigation

Quick Navigation

Archives

Archives

Drug Regulatory Authority of Pakistan

Islamabad | Karachi | Lahore | Peshawar | Quetta
Phone: 0800-03727 (Mon to Fri 08:00AM to 04:00PM)
Website: www.dra.gov.pk

Developed by MIS Division. All rights reserved to Drug Regulatory Authority of Pakistan

Contact Us
Report a Problem